Literature DB >> 23142807

Activation of prostaglandin E receptor 4 triggers secretion of gut hormone peptides GLP-1, GLP-2, and PYY.

Tamer Coskun1, Libbey S O'Farrell, Samreen K Syed, Daniel A Briere, Lisa S Beavers, Susan L Dubois, Mervyn D Michael, Jeffry B Franciskovich, David G Barrett, Alexander M Efanov.   

Abstract

Prostaglandins E1 and E2 are synthesized in the intestine and mediate a range of gastrointestinal functions via activation of the prostanoid E type (EP) family of receptors. We examined the potential role of EP receptors in the regulation of gut hormone secretion from L cells. Analysis of mRNA expression in mouse enteroendocrine GLUTag cells demonstrated the abundant expression of EP4 receptor, whereas expression of other EP receptors was much lower. Prostaglandin E1 and E2, nonselective agonists for all EP receptor subtypes, triggered glucagon like peptide 1 (GLP-1) secretion from GLUTag cells, as did the EP4-selective agonists CAY10580 and TCS2510. The effect of EP4 agonists on GLP-1 secretion was blocked by incubation of cells with the EP4-selective antagonist L161,982 or by down-regulating EP4 expression with specific small interfering RNA. Regulation of gut hormone secretion with EP4 agonists was further studied in mice. Administration of EP4 agonists to mice produced a significant elevation of plasma levels of GLP-1, glucagon like peptide 2 (GLP-2) and peptide YY (PYY), whereas gastric inhibitory peptide (GIP) levels were not increased. Thus, our data demonstrate that activation of the EP4 receptor in enteroendocrine L cells triggers secretion of gut hormones.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142807     DOI: 10.1210/en.2012-1446

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

Review 1.  Neuroimmune pharmacological approaches.

Authors:  Peter Holzer; Ahmed M Hassan; Piyush Jain; Florian Reichmann; Aitak Farzi
Journal:  Curr Opin Pharmacol       Date:  2015-09-29       Impact factor: 5.547

2.  Visceral hyperalgesia caused by peptide YY deletion and Y2 receptor antagonism.

Authors:  Ahmed M Hassan; Piyush Jain; Raphaela Mayerhofer; Esther E Fröhlich; Aitak Farzi; Florian Reichmann; Herbert Herzog; Peter Holzer
Journal:  Sci Rep       Date:  2017-01-20       Impact factor: 4.379

Review 3.  Visceral Inflammation and Immune Activation Stress the Brain.

Authors:  Peter Holzer; Aitak Farzi; Ahmed M Hassan; Geraldine Zenz; Angela Jačan; Florian Reichmann
Journal:  Front Immunol       Date:  2017-11-22       Impact factor: 7.561

Review 4.  Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides.

Authors:  Mihai Covasa; Richard W Stephens; Roxana Toderean; Claudiu Cobuz
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-19       Impact factor: 5.555

Review 5.  Interplay of Good Bacteria and Central Nervous System: Cognitive Aspects and Mechanistic Considerations.

Authors:  Mahmoud Salami
Journal:  Front Neurosci       Date:  2021-02-11       Impact factor: 4.677

Review 6.  E-type prostanoid receptor 4 (EP4) in disease and therapy.

Authors:  Viktoria Konya; Gunther Marsche; Rufina Schuligoi; Akos Heinemann
Journal:  Pharmacol Ther       Date:  2013-03-21       Impact factor: 12.310

Review 7.  Multiple Factors Related to the Secretion of Glucagon-Like Peptide-1.

Authors:  XingChun Wang; Huan Liu; Jiaqi Chen; Yan Li; Shen Qu
Journal:  Int J Endocrinol       Date:  2015-08-20       Impact factor: 3.257

Review 8.  Irritable Bowel Syndrome and Depression: A Shared Pathogenesis.

Authors:  Tatenda A Mudyanadzo; Chandanbindya Hauzaree; Oksana Yerokhina; Nalini Narayanan Architha; Hasan M Ashqar
Journal:  Cureus       Date:  2018-08-21

9.  Enteroendocrine cells couple nutrient sensing to nutrient absorption by regulating ion transport.

Authors:  Heather A McCauley; Andrea L Matthis; Jacob R Enriquez; Jonah T Nichol; J Guillermo Sanchez; William J Stone; Nambirajan Sundaram; Michael A Helmrath; Marshall H Montrose; Eitaro Aihara; James M Wells
Journal:  Nat Commun       Date:  2020-09-22       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.